Progyny, Inc. Restricted Cash, Current
Progyny, Inc. (PGNY) had Restricted Cash, Current of $1.05 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:RestrictedCashCurrent · last filed 2026-08-07
- 2026-06-30: Restricted Cash, Current $1.05M.
- 2026-03-31: Restricted Cash, Current $1.04M.
- 2025-06-30: Restricted Cash, Current $0.00.
- 2025-03-31: Restricted Cash, Current $0.00.
| Period end | Restricted Cash, Current |
|---|---|
| 2026-06-30 | $1.05M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $1.04M 10-Q · filed 2026-05-08 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-07 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |